Unichem Laboratories Ltd. — Major Shareholding Notification 2021

Apr 8, 2021

Dr. Prakash Mody

Residence: 2/C, Woodlands, 67, Dr. G.D. Marg, Mumbai - 400 026. Tel.: 2353 6940

April 5 2021

Department of Corporate Services Mr. Hari K Bombay Stock Exchange Ltd. Asst. Vice President- Operations Phiroze Jeejeebhoy Towers, National Stock Exchange of India Ltd. Dalal Street, Exchange Plaza, Bandra-Kurla Mumbai- 400 001 Complex Bandra (East), Mumbai- 400 051

Scrip Code – 506690 Symbol - UNICHEMLAB

Sub : Disclosures of Shareholding in Unichem Laboratories Limited as on 31[st] March 2021 under regulation 30(1) and 30(2) of SEBI ( Substantial Acquisition Of Shares & Takeovers) Regulations 2011.

Dear Sir,

I, being one of the Promoters of Unichem Laboratories Limited, furnish herewith on behalf of the Promoters and Promoter group, the required Disclosure in the format specified under Regulations 30(1) and 30(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 as on March 31, 2021, which we trust you will find in order.

Please acknowledge receipt.

Kindly take the same on your records.

Yours faithfully,

SD/-

Dr. Prakash A. Mody As Promoter & on behalf of Promoter Group

Copy to: Pradeep Bhandari Head – Legal & Company Secretary Unichem Laboratories Limited Unichem Bhavan, Prabhat Estate, Off S.V. Road, Jogeshwari (W) Mumbai 400 102

Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Part-A- Details of Shareholding

Part-A- Details of Shareholding
1)Name of the Target Company (TC)	Unichem Laboratories Limited
2)Name(s) of the Stock Exchange(s) where the shares of the TC are listed	National Stock Exchange (NSE) and Bombay Stock Exchange (BSE)
3)Particulars of the shareholder(s): a) Name of person(s) together with Persons Acting in Concert (PAC) whose total holding (including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the TC) is more than 25% of the voting rights of the TC. Or (b) Name(s) of promoter(s), member of the promoter group and PAC with him.	---- (1) Dr. Prakash A. Mody (2) Ms. Anita Prakash Mody
	(3) Ms. Supriya Prakash Mody
	(4)Ms.SuparnaPrakash Mody
	(5) Dr. Prakash A Mody-Suparna Mody Trust
	(6) Dr. Prakash A Mody - Shwetambari Mody Trust
	(7) Dr. Prakash A Mody-Supriya Mody Trust
4)Particulars of the shareholding of person(s) mentioned at (3) above	Number of Shares	% w.r.t. total share /voting capital wherever applicable	% of total diluted share/ voting capital of TC (*)
As of March 31, 2021, holding of: a) Shares (1) Dr. Prakash A. Mody (2) Ms. Anita Prakash Mody (3) Ms. Supriya Prakash Mody (4) Ms. Suparna Prakash Mody (5) Dr. Prakash A Mody - Suparna Mody Trust (6) Dr. Prakash A Mody - Supriya Mody Trust (7) Dr. Prakash A Mody - Shwetambari Mody Trust b) Voting Rights (otherwise than by shares) c) Warrants, d) Convertible Securities e) Any other instrument that would entitle the holder to receive shares in the TC.	3,24,99,392 13,23,400 949,936 949,936 52,016 45,052 41,283 Nil Nil Nil Nil	46.16 1.88 1.35 1.35 0.07 0.06 0.06 Nil Nil Nil Nil	Not Applicable
**Total **	3,58,61,015	50.93

SD/Dr. Prakash A. Mody (As Promoter & on behalf of Promoter Group) Place: Mumbai: Date: April 5, 2021

Part-B**

Name of the Target Company: Unichem Laboratories Limited

ame of the Target Company:Unichem Laboratories Limi	ted
Name(s) of the person and Persons Acting in Concert (PAC) with the person	Whether the person belongs to Promoter/ Promoter group	PAN of the person and PACs
Dr. Prakash A. Mody	Promoter
Ms. Anita Prakash Mody	Promoter group
Ms. Supriya Prakash Mody	Promoter group
Ms.SuparnaPrakash Mody	Promotergroup
Dr. Prakash Amrut Mody-Suparna Mody Trust	Promoter Group
Dr. Prakash AmrutMody-Shwetambari ModyTrust	PromoterGroup
Dr. Prakash AmrutMody-SupriyaModyTrust	PromoterGroup

Sd/-

Dr. Prakash A. Mody (As Promoter & on behalf of Promoter Group)

Place: Mumbai Date: April 5, 2021

Note:

1. In case of promoter(s) making disclosure under regulation 30(2), no additional disclosure under regulation 30(1) is required.

2. (*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

3. (**) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated.